Skip to main content

Table 1 Baseline demographics of type 2 diabetes mellitus (T2DM) patients with and without elevated high sensitivity Troponin I (hs-TnI) and controls

From: Predictive value of high-sensitivity troponin-I for future adverse cardiovascular outcome in stable patients with type 2 diabetes mellitus

Parameters T2DM (n = 276) Controls (n = 115) P value Elevated hs-TnI (n = 70) Normal hs-TnI (n = 206) P value
Age, years 64.4 ± 10.0 63.4 ± 7.9 0.29 68.6 ± 9.2 62.9 ± 9.9 <0.01
Male, % (n) 154 (56) 53 (61) 0.35 70 (49) 30 (21) <0.01
Body mass index, kg/m2 25.5 ± 3.5 23.6 ± 3.4 <0.01 25.4 ± 3.5 25.6 ± 3.6 0.72
Current smoker, % (n) 33 (92) 6 (7) <0.01 49 (34) 28 (58) <0.01
Hypertension, % (n) 70 (194) 15 (17) <0.01 89 (62) 132 (64) <0.01
Hypercholesterolemia, % (n) 63 (174) 30 (26) <0.01 70 (49) 61 (125) 0.10
Duration of DM, years 9.8 ± 7.6 -- -- 10.2 ± 8.7 9.7 ± 7.3 0.67
CAD, % (n) 29 (113) -- -- 60 (42) 35 (71) <0.01
Total cholesterol, mmol/L 4.6 ± 1.0 5.0 ± 0.9 <0.01 4.5 ± 1.1 4.7 ± 1.0 0.15
Triglycerides, mmol/L 1.6 ± 1.8 1.3 ± 0.8 <0.01 1.6 ± 1.1 1.6 ± 1.9 0.99
High density lipoprotein, mmol/L 1.3 ± 0.8 1.5 ± 0.4 <0.01 1.2 ± 0.4 1.3 ± 0.4 0.16
Low density lipoprotein, mmol/L 2.7 ± 0.8 3.0 ± 0.7 <0.01 2.6 ± 0.8 2.7 ± 0.8 0.55
eGFR, mL/min per 1.73 m2 81.8 ± 19.3 85.8 ± 14.1 0.03 72.0 ± 18.7 84.2 ± 18.7 <0.01
Fasting glucose, mmol/L 7.6 ± 2.3 5.1 ± 0.5 <0.01 7.6 ± 2.8 7.6 ± 2.1 0.96
HbA1c, % 7.8 ± 1.4 5.9 ± 0.4 <0.01 8.1 ± 1.7 7.7 ± 1.4 0.21
Medication
Insulin, % (n) 14 (38) 0 (0) <0.01 19 (13) 12 (25) 0.13
Aspirin, % (n) 40 (109) 0 (0) <0.01 56 (39) 34 (70) <0.01
ACEI/ARB, % (n) 60 (166) 1 (1) <0.01 77 (54) 54 (112) <0.01
Statin, % (n) 42 (115) 2 (2) <0.01 57 (40) 37 (75) <0.01
  1. Abbreviation:
  2. ACEI = angiotensin converting enzyme inhibitor; ARB = angiotensin receptor blocker; CAD = coronary artery disease; eGFR = estimated glomerular filtration rate.